Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Desire to stop drinking could be more important than therapy

14.07.2005


The positive outcomes of therapy for alcoholism may have less to do with the therapy itself and more to do with participants’ determination to quit. These are the findings of a study published today in the international Open Access journal, BMC Public Health, which provides a new analysis of previous data from Project MATCH, a clinical trial of three common forms of therapy used for the treatment of alcoholism. This analysis shows that the participants in the trial who attended all sessions did scarcely better than those who received no treatment. This contradicts previous analyses, which concluded that all three therapies for alcoholism were very effective.



The results highlight the importance of selection bias – the distortion of a statistical analysis by self-selection of participants. Individuals who come forward to take part in trials such as Project MATCH might be more likely to have positive outcomes.

“Alcoholics who decide to enter treatment are likely to reduce drinking. Those who decrease their drinking are more likely to remain in treatment”, explain Robert Cutler and David Fishbain from the department of psychiatry and behavioural sciences at the University of Miami, the authors of the study.


A fundamental principle underlying the treatment of alcoholism, and other addictions, is that psychosocial therapy - therapy involving both group meetings and personalised sessions with psychologists - is effective.

Cutler and Fishbain re-examined data from Project MATCH – a large trial carried out in the late 1990’s, which concluded that therapy for alcoholism produced excellent outcomes, although the results were controversial and inconclusive.

Project MATCH assessed the effectiveness of three different therapies: Cognitive Behavioural Therapy (CBT), Motivational Enhancement Therapy (MET) and Twelve Step Facilitation (TSF). Cutler and Fishbain investigated the relationship between the number of therapy sessions attended and how successful project MATCH participants had been at reducing and abstaining from drinking. For all patients, drinking outcome was measured in two ways, percent days abstinent (PDA) and drinks per drinking day (DDD).

In one analysis, the participants of the study were divided into three groups: those who had attended either none, one, or all twelve of the treatment sessions. Overall, Cutler and Fishbain’s data showed that participants who attended all twelve sessions had better outcomes, but there was only a very slight improvement over participants who attended no sessions. For participants who attended the twelve treatment sessions, PDA increased by 60% almost immediately, at week one, but increased by only a further four percent during the following 11 weeks of treatment. The researchers also found that participants who dropped out before the program even began had significantly better outcomes at the end of the program than those who dropped out after one session. In the long-term, the number of treatment sessions attended had a poor correlation with the outcome.

From the data, the authors conclude that “current psychosocial treatments for alcoholism are not particularly effective”, and that “most of the improvement which is interpreted as treatment effect is not due to treatment”. The authors attribute their findings to the importance of ‘self-selection’; i.e., that patients who reduce their alcohol consumption are more likely to enter or remain in treatment, and those who are drinking are more likely to drop out of treatment. According to the authors if these patient characteristics are more important than attendance at therapy, then this “would have a profound influence on alcoholism treatment because it would shift focus away from treatment components and toward patient characteristics”.

Juliette Savin | alfa
Further information:
http://www.biomedcentral.com

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>